Non-Invasive Monitoring Systems Inc (OTC Pink: NIMU) is a medical technology company that, as of its 10-K filed January 30, 2026 for the fiscal year ended July 31, 2025, has not generated meaningful revenue and carries a history of operating losses. The company disclosed that it does not expect to become profitable in the foreseeable future. Its common stock traded between $0.00 and $0.01 for the 52-week period ended July 31, 2025, and trades on the OTC Pink market. The company had 1,390 shareholders of record as of July 31, 2025, with 154,810,655 shares of common stock issued and outstanding at that date. Financing has been sourced through promissory notes from related parties, including Frost Gamma Investments Trust and Jane Hsiao. Disclosure controls and procedures were assessed as not effective as of July 31, 2025, due to identified material weaknesses. No dividends have been paid on common stock since inception.

Revenue model

The filing excerpts do not describe an active revenue model. The company has a history of operating losses and does not expect to become profitable in the foreseeable future, per the 10-K filed January 30, 2026.

Products and services

The filing excerpts do not provide specific product or service descriptions for NIMU.

Customers and end markets

The filing excerpts do not identify specific customers or end markets.

Value-chain role

The company is a development-stage or pre-revenue medical technology entity. Related-party financing has been provided by Frost Gamma Investments Trust and Jane Hsiao via promissory notes. Board members include Phillip Frost, M.D., who also serves as CEO and Chairman of Opko Health (NASDAQ: OPK). The company's principal address is 4400 Biscayne Blvd., Miami, Florida 33137, as of July 31, 2025.

Geographic exposure

The filing excerpts do not describe geographic operating exposure beyond the company's principal offices in Miami, Florida.

Source: SEC 10-K, filed 2026-01-30

Industry: Guided Missiles & Space Vehicles & Parts